(Q35553140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Gene therapy of gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

0 references

W. Hamel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531570

18 March 2024

M. Westphal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531570

18 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14531570

18 March 2024

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/978-3-7091-6090-9_18.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Acta Neurochirurgica. Supplementum

18 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

125-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression

18 March 2024

2

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

18 March 2024

4

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

18 March 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Combined radiation and p53 gene therapy of malignant glioma cells

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

18 March 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

18 March 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors?

18 March 2024

13

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

18 March 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adeno-retroviral chimeric viruses as in vivo transducing agents.

18 March 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

18 March 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Cyanide bystander effect of the linamarase/linamarin killer-suicide gene therapy system

18 March 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

18 March 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

18 March 2024

26

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates

18 March 2024

28

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.

18 March 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

18 March 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro

18 March 2024

32

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma

18 March 2024

33

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with Herpesvirus genetic information

18 March 2024

35

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine

18 March 2024

36

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma

18 March 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

18 March 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

18 March 2024

40

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.

18 March 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

(E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells

18 March 2024

43

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

18 March 2024

44

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas

18 March 2024

46

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha

18 March 2024

47

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.

18 March 2024

50

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas

18 March 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity

18 March 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir

18 March 2024

54

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines.

18 March 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

18 March 2024

56

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

18 March 2024

57

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant

18 March 2024

58

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Telomerase as a therapeutic target for malignant gliomas.

18 March 2024

59

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.

18 March 2024

61

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice

18 March 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors.

18 March 2024

64

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells

18 March 2024

65

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated p53 gene therapy for human gliomas

18 March 2024

66

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model

18 March 2024

67

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene

18 March 2024

69

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma

18 March 2024

70

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector

18 March 2024

71

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.

18 March 2024

72

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.

18 March 2024

73

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

18 March 2024

74

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

18 March 2024

76

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model

18 March 2024

80

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

18 March 2024

82

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

18 March 2024

84

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Anticellular Effects of 9-(2-Hydroxyethoxymethyl) Guanine Against Herpes Simplex Virus-transformed Cells

18 March 2024

85

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

18 March 2024

86

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

18 March 2024

88

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy

18 March 2024

90

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

18 March 2024

91

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

18 March 2024

92

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

18 March 2024

93

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer

18 March 2024

96

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

18 March 2024

97

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.

18 March 2024

98

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol

18 March 2024

99

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

18 March 2024

100

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

18 March 2024

101

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

18 March 2024

102

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

18 March 2024

103

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

18 March 2024

105

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

18 March 2024

107

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

18 March 2024

108

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy

18 March 2024

110

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

18 March 2024

111

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

An antisense EGFR oligodeoxynucleotide enveloped in Lipofectin induces growth inhibition in human malignant gliomas in vitro

18 March 2024

113

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells.

18 March 2024

114

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.

18 March 2024

115

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation

18 March 2024

116

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells

18 March 2024

117

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

18 March 2024

121

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

18 March 2024

122

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

18 March 2024

123

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model

18 March 2024

125

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo

18 March 2024

126

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Long-term survival after gene therapy for a recurrent glioblastoma

18 March 2024

128

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

18 March 2024

130

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

18 March 2024

131

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha.

18 March 2024

132

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Structural alterations of the epidermal growth factor receptor gene in human gliomas

18 March 2024

133

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Basic study on gene therapy of human malignant glioma by use of the cationic multilamellar liposome-entrapped human interferon beta gene

18 March 2024

134

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells

18 March 2024

135

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.

18 March 2024

136

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

18 March 2024

137

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-6090-9_18

18 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531570%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference